Biotechnologijos institutas yra  mokslinių tyrimų institucija, siekianti užtikrinti valstybės pažangą sparčiai besivystančiose gyvybės mokslų ir biotechnologijų srityse, plėtoti tarptautinio lygio molekulinės biotechnologijos tyrimus, skatinti tarpdisciplininius tyrimus bei mokslo ir verslo bendradarbiavimą

Vykdyti užsienio projektai

Spausdinti

7 BENDROJI PROGRAMA

Small molecule inhibitors of the trimeric influenza virus polymerase complex (FLUINHIBIT). 2008-2010. dr. G.Žvirblis

6 BENDROJI PROGRAMA

Meganucleases for gene replacement. 2006-2008. prof. dr. V.Šikšnys

Inhibition of Cancer by Disrupting Interaction Between Polo-like Kinase 1 Polo-box Domain and Spindle Targets. 2006-2008. dr. J.Matulienė

A multidisciplinary approach to the study of DNA enzymes down to the single molecule level. 2005-2009. prof. dr. V.Šikšnys

Targeting newly discovered oxygen sensing cascades for novel cancer treatments, biology equipment, drugs. 2004-2008. dr. A.Kanopka

Molecular modeling-based characterization of protein complexes involved in DNA repair. 2004-2006. dr. Č.Venclovas

Drug design by structural thermodynamics. 2004-2006. dr. D.Matulis

ScanBalt Competence Region – a model case to enhance European competitiveness in life sciences, genomics and biotechnology for health on a global scale. 2004-2006. habil. dr. A.Pauliukonis

Rational design and comparative evaluation of novel genetic vaccines. 2004-2008. prof. K.Sasnauskas

5 BENDROJI PROGRAMA

Support for the integration of “newly associated states” in the European research area “Biotechnology Centre of Excellence of Lithuania”. 2003-2006

Development of highly special enzymes for genome manipulation. prof. 2003-2004. dr. V.Šikšnys

Enhanced Laboratory Surveillance of Measles. 2002-2005. prof. K.Sasnauskas

Combined immune and gene therapy for chronic hepatitis. 2001-2003. prof. K.Sasnauskas

Comprehensive risk analysis of dioxins: development of methodology to assess genetic susceptibility to developmental disturbances and cancer. 2000-2003. dr. A.Kanopkas

Bivalent hantavirus vaccine for Europe: Different approaches and evaluation in animal models. 1999-2003. prof. K.Sasnauskas

4 BENDROJI PROGRAMA

Molecular monitoring and pathological role of HCV, HGV and altered HBV genomes in the Baltic countries. 1998-2001. prof. K.Sasnauskas

Detection, identification and typing of the Mycobacterium tuberculosis in the Baltic countries. 1998-2003. dr. P. Stakėnas

Recombinant viral particulate proteins as tools for new vaccines and diagnostics. 1994-1997. prof. K.Sasnauskas

HOWARD HUGHES MEDICINOS INSTITUTAS

Structural characterization of protein interactions in DNA replication, repair and recombination processes through molecular modelling. 2006-2010. dr. Č. Venclovas

Towards engineering of restriction enzymes. 2003-2004. prof. dr. V. Šikšnys

Bioinformatics-guided engineering of DNA methyltransferases. 2003-2004. dr. Č. Venclovas

Sequence recognition and base flipping by DNA methyltransferases: Structural studies and redesign for novel functions. 2001-2005. prof. S..Klimašauskas

Principles of restriction enzymes specificity. 2001-2005. prof. dr. V. Šikšnys

Combination of improved methods with expert knowledge to derive models of protein structure at low sequence homology. 2001-2005. dr. Č. Venclovas

Mechanisms of specific protein-DNA recognition and modification. 1996-2000. prof. S. Klimašauskas

NACIONALINIS SVEIKATOS INSTITUTAS

Methylome profiling via DNA Methyltransferase directed labelling. 2008-2010. prof. S. Klimašauskas

WELLCOME FONDAS

Cross-talk between functional domains of BfiI restriction endonuclease. 2005-2006. prof. dr. V. Šikšnys

Restriction enzymes with novel restriction mechanisms. 2001-2003. prof. dr. V. Šikšnys

Calorimetric Studies of DNA- Restriction Enzyme Interactions. 1999-2001. prof. dr. V. Šikšnys